SANTA CLARA, Calif. , July 22, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the second quarter and six months ended June 30, 2024 , after the close of U.S. financial markets on Monday, August 5, 2024 . Doug Murphy-Chutorian , M.D.,... Read More

SANTA CLARA, Calif. , May 28, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, announced today that its board of directors has adopted bitcoin as its primary treasury reserve asset. In addition, Semler Scientific announced that it has purchased 581 bitcoins for an aggregate amount of $40... Read More

2024 Q1 highlights compared to the corresponding period of 2023: First quarter revenues were $15.9 million , a decrease of 13% First quarter net income was $6.1 million , an increase of 22% Cash, cash equivalents and restricted cash balance increased to $62.9 million SANTA CLARA, Calif. , May 7, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical... Read More

SANTA CLARA, Calif. , April 23, 2024 /PRNewswire/ -- Semler Scientific, Inc . (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the first quarter ended March 31, 2024 , after the close of U.S. financial markets on Tuesday, May 7, 2024 . Doug... Read More

2023 Q4 and full year highlights compared to the corresponding period of 2022: Fourth quarter revenues were $15.1 million , an increase of 9% Fourth quarter net income was $4.2 million , an increase of 31% Full year revenues were $68.2 million , an increase of 20% Full year net income was $20.6 million , an increase of 44% Cash balance increased to $57.3 million SANTA CLARA, Calif. , March 5, 2024 /PRNewswire/ -- Semler... Read More

SANTA CLARA, Calif. , Feb. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 , after the close of U.S. financial markets on Tuesday, March 5, 2024.... Read More

20 23 Q3 highlights: Revenue of $16.3 million , an increase of 16% compared to the corresponding period of 2022 Net income of $5.5 million , an increase of 50% compared to the corresponding period of 2022 Quarter-ending cash, cash equivalents and short-term investments of $56.0 million SANTA CLARA, Calif. , Nov. 9, 2023 /PRNewswire/ -- Semler Scientific, Inc . (Nasdaq: SMLR), a company that develops, manufactures and markets... Read More

SANTA CLARA, Calif. , Oct. 26, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the third quarter and first nine months ended September 30, 2023 , after the close of U.S. financial markets on Thursday, November... Read More

SANTA CLARA, Calif. , Aug. 31, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced Renae Cormier , CFO, will participate in the following investor conference: Lake Street Capital Markets 7 th Annual Best Ideas Growth (BIG7) Conference Date: September 14,... Read More

2023 Q2 highlights: Revenue was $18.6 million , an increase of 25% compared to the corresponding period of 2022 Net income was $5.9 million , an increase of 44% compared to the corresponding period of 2022 Cash, cash equivalents and short-term investments of $51.8 million SANTA CLARA, Calif. , Aug. 10, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative... Read More

SANTA CLARA, Calif. , July 28, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the second quarter ended June 30, 2023 , after the close of U.S. financial markets on Thursday, August 10, 2023 . Doug... Read More

SANTA CLARA, Calif. , July 11, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced the appointment of a chief financial officer (CFO), record quarterly revenues expected for the second quarter of 2023 and a strategic streamlining. "We are pleased to... Read More

SANTA CLARA, Calif. , June 23, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it is set to join the Russell 2000 ® and 3000 ® Indexes at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on... Read More

2023 Q1 highlights: Revenue was $18.2 million , an increase of 30% compared to the corresponding period of 2022 Net income was $5.0 million , an increase of 48% compared to the corresponding period of 2022 Cash, cash equivalents and short-term investments of $43.0 million SANTA CLARA, Calif. , May 10, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative... Read More

SANTA CLARA, Calif. , May 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended March 31, 2023 , after the close of U.S. financial markets on Wednesday, May 10, 2023 . Doug Murphy-Chutorian , M.D., interim chief... Read More

SANTA CLARA, Calif. , April 28, 2023 /PRNewswire/ -- The board of directors of Semler Scientific, Inc. (Nasdaq: SMLR), is pleased to announce that it has appointed Doug Murphy-Chutorian , M.D., former CEO and a current member of the board of directors as chief executive officer (CEO) on an interim basis with immediate effect. The board intends to conduct a global search for a permanent CEO. "We are delighted that Doug has... Read More

Eric Semler Appointed as Chairman SANTA CLARA, Calif. , April 19, 2023 /PRNewswire/ -- - Semler Scientific, Inc. (Nasdaq: SMLR) today announced that Eric Semler and William H.C. Chang (together, the "Investors"), who collectively beneficially own more than 20% of Semler Scientific's outstanding shares, will immediately join Semler Scientific's board of directors as new independent directors. Mr. Semler will join the board as... Read More

SANTA CLARA, Calif. , April 5, 2023 /PRNewswire/ -- Semler Scientific, Inc. ( Nasdaq : SMLR ), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Wayne T . Pan, Ph .D., M .D., and head of corporate communications and business strategy, Renae Cormier , will present a company overview at the 22nd Annual... Read More

SANTA CLARA, Calif. , April 3, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, commented on the recent Centers for Medicare and Medicaid Services (CMS) 2024 Medicare Advantage and Part D Final Rate Announcement. "Semler Scientific remains confident that screening for peripheral artery... Read More

2022 Q4 and Full Year highlights compared to the corresponding period of 2021: Fourth quarter revenue was $13.8 million , an increase of 20% Fourth quarter net income was $3.2 million , an increase of 113% Full year revenue was $56.7 million , an increase of 7% Full year net income was $14.3 million , a decrease of 17% Cash at December 31, 2022 increased to $43.1 million , including short-term investments Corporate update:... Read More

SANTA CLARA, Calif. , March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, announces that Doug Murphy-Chutorian , M.D. has informed the board of directors of his intention to step down from his position as chief executive officer (CEO) of Semler Scientific and assist for a transition... Read More

SANTA CLARA, Calif. , March 10, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2022 , after the close of U.S. financial markets on Tuesday, March 21, 2023 . Doug Murphy-Chutorian ,... Read More

SANTA CLARA, Calif. , March 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers (HCPs), today announced the publication of a study in the peer-reviewed Journal of Preventive Medicine with data supporting the use of QuantaFlo as an aid to measure hemodynamics related to heart dysfunction (HD).... Read More

SANTA CLARA, Calif. , Dec. 14, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that a study was published in the peer-reviewed AJPM Focus with data collected using the company's QuantaFlo® PAD test under real-world conditions, illustrating the benefits of PAD in-home... Read More

SANTA CLARA, Calif. , Dec. 12, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced an up to $5.0 million investment in privately-held Monarch Medical Technologies, LLC (Monarch) through the purchase of a senior secured convertible promissory note. Repayment of the note is secured... Read More